0

Incorporated in 2010, Manipal Health Enterprises Limited is a healthcare service providers, operating a large network of multi-specialty hospitals, clinics, and diagnostic centres across the country. It is part of the Manipal Group, founded by T. M. A. Pai.vThe company offers a wide range of healthcare services including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare. Its hospitals are equipped with advanced medical technology and are staffed by experienced medical professionals. Manipal Health focuses on delivering quality, patient-centric care and expanding access to healthcare through strategic acquisitions, partnerships, and continuous investment in medical infrastructure and digital health initiatives. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds. They are operating 21 clinics as of March 31, 2026. As of March 31, 2026, the company had 24,240 full-time employees across its hospitals and corporate functions. The workforce comprised 11,048 nurses, 6,362 paramedics, and 6,830 administrative employees, supporting its healthcare operations and patient services. Competitive Strengths:

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: #: Issue Objects 1: Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the Material Subsidiaries, Manipal Hospitals Private Limited 2: Acquisition of minority stake in the stepdown Subsidiary, Sahyadri Hospitals Private Limited 3: General corporate purposes 4: Issue Expenses : Total

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App